Sofinnova Partners

Cure51 is a cancer research company that decodes the biology of exceptional cancer survivors ("cancer outliers") using molecular profiling and computational biology, collecting patient data on its Patient Profile Platform.

AI & Machine LearningBiotechDigital HealthHealthtech

PCPaloma Cejas(Founder, Head of Translational Research)inRNRémy Nicolle(Founder, Senior Advisor Computational Biology)

Co-investorsHIHitachi VenturesKIKima VenturesLILifeX Ventures

DBV Technologies develops the VIASKIN® patch, a non-invasive, skin-based immunotherapy technology for treating food allergies and other immunological disorders.

BiotechDigital HealthHealthtechMedical DevicesChâtillon, FR

PMPharis Mohideen(Executive Officer)inDTDaniel Tasse(Executive Officer, Director)inVBVirginie Boucinha(Executive Officer)in

BoardMailys Ferrere(Director)Michael Goller(Director)Ravi Madduri Rao(Director)

Co-investorsCACapDecisif ManagementKAKarista

An AI radiology platform that automates the reporting process and hosts 80+ leading imaging AI vendors.

Co-investorsMEMeridian Health VenturesXPXPRENEURSPEPentathlon Ventures

DMC Biotechnologies is a U.S.-based biomanufacturer that uses precision fermentation and its Dynamic Metabolic Control platform to produce bio-based specialty chemicals and ingredients, such as L-alanine and fermented inositols.

BiotechClimate TechNew MaterialsBoulder, US

Matthew Lipscomb(Director)Josh Yelen(Executive Officer)JFJim Flatt(Executive Officer, Director)in

BoardJosko Bobanovic(Director)RVRob van der Meij(Director)inAlastair Cooper(Director)

Co-investorsBRBreakthrough Energy VenturesCICIBUS ENTERPRISE FUND II LPBOBoulder VenturesCACapricorn Venture PartnersMIMichelin Ventures

DNA Script develops enzymatic DNA synthesis technology, producing nucleic acids for research and biotech applications.

BiotechDeep TechHardwareParis, FR

TYThomas Ybert(Founder)inXGXavier Godronin

Co-investorsCACatalio Capital Management, LPCOCoatue ManagementILIllumina VenturesKUKurma PartnersM M VenturesCACasdin Capital

Elicit Plant develops agricultural solutions that trigger plants' natural defenses to help field crops resist water stress and adapt to climate change.

AgTechBiotechClimate Tech

Olivier Goulay(Founder)in

Co-investorsEUEuropean Circular Bioeconomy Fund

Endoron Medical develops transcatheter anchoring and sealing devices for aortic procedures, including Aortodock (a nitinol docking system to stabilize transcatheter valves in low-calcium aortic regurgitation and stenosis anatomies) and Aortoseal (a multi-stapling fixation and sealing system for endovascular aneurysm repair grafts).

HardwareHealthtechMedical Devices

Enginzyme develops a technology platform for sustainable chemistry applications aimed at removing carbon dioxide from the atmosphere.

BiotechCleantechClimate TechNew MaterialsStockholm, SE

ADAymeric de Gantès(CEO)inJosefin Lannefors(Chief Commercial Officer)inMAMarco Antonio Saucedo(Chief Technology Officer)in

Co-investorsINIndustrifondenJUJude GomilaNANavigare Ventures

Extracellular is a biomanufacturing company that helps cell-based product developers in cultivated meat, plant cell culture, and bioactives accelerate discovery, overcome production challenges, and commercialize their products.

Advanced ManufacturingBiotechFoodTechNew Materials

WMWill Milligan(CEO & Founder)in

Co-investorsBIBig Idea VenturesFFFFFNENewland SyndicateUNUnruly Capital5A5AM VenturesAGAgent Capital+8 more

F2G develops medicines to treat serious fungal diseases where existing therapies have failed or are ineffective.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsADAdvent Life SciencesAIAisling CapitalAMAMR Action FundASAstellas Venture Management LLCBRBrace PharmaSUSunstone Capital+4 more

Forth Therapeutics is an Edinburgh/Cambridge-based biotech spinout from the University of Edinburgh developing precision, omics-driven therapeutics to halt or reverse fibrosis across multiple organ systems.

Co-investorsOLOld College Capital

Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women.

BiotechFemTechHealthtech

Colleen Acosta, PhD(CEO, Co-Founder)Johan van Hylckama Vlieg, PhD(CSO, Co-Founder)

Co-investorsANAngelini VenturesINIndaco Venture PartnersOMOMX VenturesBIBill & Melinda Gates Foundation

Galvanize provides customized technical education and training programs to help enterprise teams build skills in AI, machine learning, XP and Agile practices, data pipelines, and cloud operations.

AI & Machine LearningEdTechEnterprise SoftwareFuture of WorkDenver, US

Christopher C. Onan(Executive Officer)James Deters(President and Chief Executive Officer)LMLawrence Mandes(Managing Director, New Markets)in

BoardDaniel Pianko(Director)Tatiana Goldstein(Director)Jerrold Miller(Director)

Co-investorsTETeamworthy VenturesTHThe Colorado Impact FundVTVTF CapitalALAlly Bridge GroupCACatalyst InvestorsFIFidelity Investments+5 more

Galvanize Climate Solutions is an investment firm focused on the energy transition, deploying capital across areas such as climate risk analytics and clean energy.

CleantechClimate TechEnergy

VMVeery Maxwell(Founder)in

Co-investorsABABS Capital PartnersBLBlue Haven InitiativeGAGalvanize Climate SolutionsALAlly Bridge GroupFIFidelity InvestmentsGIGilmartin Capital LLC+4 more

GenSight Biologics develops clinical-stage gene therapy treatments, with a lead candidate (GS010/LUMEVOQ) in development for rare genetic diseases.

BiotechDigital HealthHealthtechMedical DevicesParis, FR

BGBernard Gilly(Executive Officer, Director)inJCJean-Philippe Combal(Executive Officer)inThomas Gidoin(Executive Officer)Didier Pruneau(Executive Officer)inNitza Thomasson(Executive Officer)in

BoardFlorent Gros(Director)

Co-investorsAGAgoranovABAbingworth

GFBiochemicals develops plant-based chemical ingredients derived from levulinate technology to replace harmful petrochemical components in consumer products such as shampoos, detergents, and cosmetics.

BiotechCircular EconomyCleantechClimate TechNew MaterialsAix en Provence, FR

MFMathieu Flamini(Founder)inPasquale Granata(Founder)in

GlycoEra develops glycan-based therapeutics, applying glycoengineering technology to create biologic drugs.

BiotechHealthtechNewton, US

Ganesh V. Kaundinya(President & CEO)in

Co-investors5A5AM VenturesCACatalio Capital Management, LPLILifeArc VenturesRORoche Venture FundSISixty Degree CapitalAGAgent Capital+1 more

HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies.

AI & Machine LearningBiotechHealthtech

BoardBBBruce Booth(Chairman)in

Co-investorsATAtlas VentureB B Capital GroupB4B4 CapitalMRMRL Ventures FundPIPivotal Life SciencesSOSolasta Ventures+2 more

Ingenix builds an AI "Reasoning Engine" using an approach it calls Modality Fusion to integrate biological data across modalities and scales.

AI & Machine LearningBiotechDeep Tech

ADAdam Dancewicz(Founder)

Co-investorsINInovo VCOTOTB Ventures

Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases.

BiotechMedical Devices

Co-investorsEUEuropean Investment BankANAndera PartnersCLClaret Capital PartnersNENew Enterprise Associates (NEA)SASamsara BioCapitalBIBiotechnology Value Fund+1 more

iOmx Therapeutics is a biotech company developing novel cancer therapies.

AI & Machine LearningBiotechHealthtechMedical DevicesMunich, DE

Co-investorsM M VenturesMIMIG Capital AG

Julier Medical is a Paris-based, pre-clinical medical device startup developing a mechanical thrombectomy device to remove blood clots and restore blood flow in acute ischemic stroke patients.

The National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services.

HealthtechImpact & Social Good

Co-investorsYSYsios CapitalBIBioGeneration VenturesEPEpidarex CapitalRORoche Venture FundSCScottish National Investment Bank

Kiro is a health technology company that transforms healthcare data into actionable intelligence for patients and healthcare providers.

AI & Machine LearningDigital HealthHealthtech

Co-investorsKIKima Ventures

Latent Labs develops generative AI models for protein design and builds biological platforms to validate AI-driven designs.

AI & Machine LearningBiotechDeep TechLondon, GB

SKSimon Kohl(Founder)in

BoardJohn Cassidy(Director)TKTony Kulesa(Director)in

Co-investors8V8VCFLFlying Fish VenturesISIsomer CapitalKIKindred CapitalPIPillar VCRARadical Ventures+2 more

LimFlow develops a medical device system for the treatment of chronic limb-threatening ischemia.

HealthtechMedical Devices

Co-investorsLOLongitude Capital

Irish company developing an advanced neurostimulation device.

HealthtechPlymouth, US

Dan Sachs(Director)PCPeter Crosby(Executive Officer, Director)inJason Hannonin

BoardMRManus Rogan(Director)inAPAntoine Papiernik(Director)in

Co-investorsFOFountain Healthcare PartnersIRIreland Strategic Investment FundSESeventure PartnersVIViking GlobalALAlly Bridge GroupGIGilde Healthcare+1 more

Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops.

AgTechBiotechDeep Tech

Ricardo Garcia de Albain

Co-investorsGEGenoa VenturesKUKurma PartnersCACasdin Capital

Micropep develops natural crop protection solutions using micropeptides—short protein molecules that regulate plant genes and proteins—for farmers seeking sustainable alternatives.

AgTechAI & Machine LearningBiotechClimate TechToulouse, FR

TLThomas Laurent(Founder & Strategic Advisor)inGGGeorg Goeres(Chief Executive Officer)inMikael Courbot(Chief Technology Officer)in

Co-investorsSUSupernova InvestFAFall Line CapitalZEZebra Impact Ventures

Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases.

BiotechMedical Devices

ARAdele Rowley(Chief Scientific Officer)in

Co-investorsBIBioGeneration VenturesEPEpidarex CapitalRORoche Venture FundSCScottish National Investment Bank

Mission Therapeutics develops therapeutics targeting deubiquitylating enzymes (DUBs), such as USP30, which regulate ubiquitylation and processes including mitophagy and protein homeostasis.

BiotechHealthtech

Co-investorsPFPfizer Venture InvestmentsRORoche Venture FundRORosetta Capital Ltd.SRSR One Capital ManagementIPIP Group

Mnemo Therapeutics is a Paris-based clinical-stage biotech developing cell therapies using its EnfiniT epigenetic antigen discovery platform to target tumor-specific antigens for CAR-T therapies.

Co-investorsALAlexandriaCACasdin CapitalREREDMILE

Modality is a Boston-based platform for evidence-based clinical skill-building using customizable AI patients.

EdTechBoston, US

Co-investorsTETechstars

Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.

BiotechMedical Devices

MDMark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)CKCalvin Kuo(Scientific Co-Founder)KFKatie Fanning(President & Chief Executive Officer)in

Co-investorsARARCH Venture PartnersJDJDRF T1D FundMRMRL Ventures FundONOno Venture Investment, Inc.PFPfizer Venture InvestmentsABAbbVie+6 more

Muna Therapeutics is a biotechnology company developing therapeutics, with a focus on drug discovery involving medicinal chemistry.

BiotechDeep TechHealthtechLongevity

RBRita Balice-Gordon(Founder)inJVJoachim Vilstrup(Head of Protein Chemistry and Structural Biology; scientific co-founder)inMDMichel Detheux(Chief Executive Officer & Board Director)inAHAnders Hinsby(Chief Operating Officer)inNPNiels Plath(Chief Scientific Officer)inJBJakob Busch-Petersen(Chief Development Officer)in

Co-investorsDRDroia VenturesSASanofi VenturesV-V-Bio Ventures

Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment.

BiotechMedical DevicesLondon, GB

Co-investorsBRBrandon Capital PartnersNONovo HoldingsABAbingworth

nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications.

BiotechDeep TechMedical DevicesBoston, US

LGLuke Gilbert, PhD(Founder)Keith Joung, MD, PhD(Founder)DLDavid Liu, PhD(Founder)ALAngelo Lombardo, PhD(Founder)Luigi Naldini, MD, PhD(Founder)JWJonathan Weissman, PhD

Co-investorsATAtlas VentureNENewpath Partners5A5AM VenturesARARCH Venture PartnersDCDCVC (Data Collective)F-F-Prime Capital+11 more

Nephris is a biotech company developing first-in-class therapies for diabetic chronic kidney disease.

BiotechDigital Health

Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.

HardwareHealthtechMedical Devices

Co-investorsATAtlantic Bridge VenturesCLClaret Capital PartnersFOFountain Healthcare PartnersMVMVM Life Science PartnersENEnterprise IrelandEQEQT Life Sciences+1 more

Nitrase Therapeutics is a clinical-stage biopharmaceutical company using its NITROME platform to develop therapeutics based on nitrases, a class of enzymes it discovered that drive protein nitration.

BiotechHealthtechLongevity

Irene Griswold-Prenner(Founder & Chief Executive Officer)in

Co-investorsDEDementia Discovery FundMIMission BiocapitalSVSV Health InvestorsABAbbVieMIMission Bay Capital

Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.

BiotechHealthtechMedical Devices

ILIlise Lombardo(Chief Executive Officer)inVKVolker Knappertz(Executive Vice President of Research & Development)inMSMichael Samar(Chief Financial Officer)inRLRob Lasser(Chief Medical Officer)in

Co-investorsBIBioMedPartnersJEJeito CapitalRORoche Venture FundEQEQTEQEQT Life SciencesFOForbion+2 more

NovaMeat develops plant-based protein food products, positioning them as part of a new culinary tradition.

FoodTech

GSGiuseppe Scionti(Founder)in

Co-investorsAUAurum Venture PartnersCACarbonJOJoyance PartnersUNUnovis Asset ManagementVUVU Venture PartnersFOForbion+1 more

The page is a Vietnamese-language sports streaming site (90Phut TV / 90Phutr.tv, also called Vaoroi TV) offering free live football streaming links, match schedules, standings, results, news, and betting odds.

Media & EntertainmentSports TechHà Nội, VN

Co-investorsAIAisling CapitalM M VenturesNENew Enterprise Associates (NEA)SOSofinnova Ventures

BiotechPrinceton, US

Gerald Wisler(Executive Officer, Director)Christian Schade(Executive Officer)

BoardGSGraziano Seghezzi(Director)inDavid Mott(Director)George Horner(Director)

Co-investorsNENew Enterprise Associates (NEA)

OneBio Sciences provides clinical-grade single-cell RNA sequencing analysis of tumor samples to support cancer diagnostics and drug development.

AI & Machine LearningBiotechDigital HealthMedical DevicesParis, FR

CVCéline Vallot(Co-founder & CSO)in

Co-investorsBLBlast.ClubGAGalion.exeKIKima VenturesPOPolytechnique VenturesINInvusREREDMILE

P2 Science develops green chemistry platform technologies (including its PIOz ozonolysis and PICE polymerization processes) that convert renewable, plant-based oils into functional intermediates, specialty ingredients, and polymers.

BiotechCircular EconomyCleantechNew MaterialsWoodbridge, US

PAPaul Anastas(Co-founder)Patrick Foley(Co-founder & President)inNeil A. Burns(Executive Officer, Director)OEOihana Elizalde(Chief Executive Officer)inBCBrian Chan(Chief Financial Officer)inKevin Gallagher(Director)

Co-investorsXEXeraya CapitalCICircular Innovation FundCOConnecticut InnovationsELElm Street VenturesEMEmerald Technology Ventures AgHGHG Ventures+2 more

Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.

HardwareHealthtechMedical Devices

Erez Golan(Founder)in

Co-investorsACAccelmed PartnersCLClal Biotechnology IndustriesINIndaco Venture PartnersKRKreos CapitalINInnogest Capital

PinCell is a biotech company developing pharmaceutical treatments in the field of dermatology, based on research into skin biology and skin disorders.

BiotechMedical Devices

CPCarlo Pincelli(CMO, Co-Founder, Co-Inventor)inAMAlessandra Marconi(Co-Founder, Co-Inventor)inAAAntonino Amato(Chairman & CEO)inBBBrydon Bennett(CSO)in

Pixium Vision SA developed the PRIMA System, an implantable device for treating late-stage macular degeneration, and ran clinical trials in Europe.

BiotechHealthtechMedical Devices

Co-investorsAGAgoranovABAbingworthBPBpifranceOMOmnes Capital

Prometheus Materials develops low-carbon cement and concrete technology, marketed as ProZERO, using algae-based biotechnology as a replacement for portland cement in ready-mix and construction applications.

CleantechConstruction TechNew MaterialsLongmont, US

LBLoren Burnett(President, CEO and Co-founder)inSCSherri Cook(Advisor and Co-founder)inMHMija Hubler(Engineering Advisor and Co-founder)inWSWil Srubar III(Technology Advisor and Co-founder)inJGJaclyn Gruber(Chief Marketing Officer)in

BoardJosko Bobanovic(Director)

Co-investorsAUAutodesk Foundation

ProQR develops medicines for patients with unmet medical needs, focusing on therapeutic development in biotech.

BiotechHealthtechMedical DevicesLeiden, NL

Co-investorsINInvivo Capital PartnersPOPontifax Venture CapitalAEAescap Life Sciences

Protera builds functional protein ingredients for the food industry using its madi platform, which combines generative AI and computational biology to design novel proteins produced through precision fermentation.

AI & Machine LearningBiotechFoodTech

Co-investorsSOSOSV

Qorium develops cell-cultured leather grown from a single animal cell sample, producing uniform collagen sheets that integrate into existing tannery and leather-goods production processes.

BiotechCircular EconomyNew Materials

Co-investorsBRBrightlands Venture PartnersINInvest-NL

Recor Medical develops the Paradise Ultrasound Renal Denervation system, a therapy that uses ultrasound technology to lower blood pressure in patients with hypertension.

BiotechHardwareHealthtechMedical DevicesPalo Alto, US

JSJacques Seguin(Director)in

BoardAndrew M. Weiss(Executive Officer, Director)APAntoine Papiernik(Executive Officer, Director)inKazumichi Kobayashi(Director)F. Thomas Watkins(Director)Frank Litvack(Director)

Co-investors41415 Capital

Redona Therapeutics is a drug discovery company co-founded by Harvard Medical School investigators focused on novel areas of biology.

AI & Machine LearningBiotechBoston, US

George Daley(Co-founder)Richard Gregory(Co-founder)Frank Slack(Co-founder)Piotr Sliz(Co-founder)inKSKazumi Shiosaki(President & CEO)in

Co-investorsASAstellas Venture Management LLCOUOUP (Osage University Partners)

Redx is a clinical-stage biotechnology company developing small molecule targeted medicines focused on fibrotic diseases, leveraging ROCK pathway inhibitors and novel targets.

BiotechHealthtechMedical Devices

LALisa Anson(Chief Executive Officer)

BoardBernard Coulie(Independent Director)

Co-investorsABAbingworthREREDMILE5A5AM VenturesPEPerscitus LLP

NodThera develops clinical-stage small-molecule therapies targeting inflammation for cardiometabolic and neuroinflammatory diseases, including cardiovascular disease, metabolic dysfunction, and neuroinflammation.

BiotechHealthtech

GMGeoff McDonough(Executive Team / Board)inCGChris Guiffre(Executive Team)inAPAlan P. Watt(Executive Team)inJGJyothis George(Chief Medical Officer)inNCNick Clarke(Executive Team)in

Co-investors5A5AM VenturesEPEpidarex CapitalF-F-Prime CapitalSASanofi Ventures

Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.

Co-investorsINInvusREREDMILESASanofi Ventures

Provides pharmaceutical R&D services via the Cyto-Mine machine for single-cell analysis and characterisation.

Co-investors2424 HaymarketQVQVenturesPRProvidence Investment Company LimitedREREDMILE

Synthace provides a software platform for experimental design and lab automation, enabling researchers to run Design of Experiments (DOE) workflows across multiple automated laboratory instruments and devices.

AI & Machine LearningBiotechCloud ComputingDeep TechSaaS

Markus Gershater, PhD(Chief Executive Officer & Co-Founder)

Co-investors1111.2 CapitalFUFuture Planet CapitalHOHorizons VenturesUKUK Innovation & Science Seed FundAMAmadeus Capital PartnersSOSOSV

T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB

Co-investorsCACambridge Innovation CapitalF-F-Prime CapitalSASanofi VenturesBUBusiness Growth FundDIDigitalis VenturesUNUniversity of Cambridge Enterprise

Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye.

BiotechDigital HealthHealthtechLongevityMedical DevicesWarren, US

HBHENRIC BJARKE(Chief Executive Officer)in

Co-investorsADAdBio partnersF-F-Prime CapitalQIQiming Venture Partners USAQIQiming Venture Partners

TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas.

BiotechDeep TechMedical DevicesNew Materials

CBChristophe Bancel(Co-founder & CEO)inMPMaria Pereira(Co-inventor of the technology; leads the Innovation Hub)in

Co-investorsCACapDecisif ManagementCACathay HealthKAKaristaCACathay InnovationEUEuropean Investment BankOMOmnes Capital

Tulyp Medical develops the Tulyp System, an investigational pressure-controlled perfusion device with a microaxial pump cannula designed to restore blood flow to the leg in patients on femoral arterial support (VA-ECMO, IABP, pVAD) who are at risk of acute limb ischemia.

HardwareHealthtechMedical Devices

A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.

BiotechSan Diego, US

David Johnson(Executive Officer, Director)Cam Gallagher(Director)Scott L. Glenn(Director)in

Co-investorsCHChiesi VenturesDEDecheng CapitalPAPappas CapitalSOSofinnova VenturesVEVedanta CapitalVIViking Global+4 more

Hélène Briand(Founder)Mac Millan(Founder)

Verona Pharma develops treatments for chronic lung conditions.

BiotechHealthtechLondon

Jan-Anders Karlsson(Executive Officer, Director)inPSPeter Spargo(Executive Officer)inPatrick Humphrey(Director)Ken Cunningham(Director)Kenneth Newman(Executive Officer)Anders Ullman(Director)

Co-investorsACAccess BiotechnologyAIAisling CapitalANAndera PartnersFOForesite CapitalFRFrazier Life SciencesNENew Enterprise Associates (NEA)+4 more

RefleXion Medical develops autonomous radiotherapy technology that uses biological signals from cancer cells to detect and treat solid tumors in the lung or bone.

BiotechHealthtechMedical DevicesHayward, US

Akshay Nanduri(Founder)Samuel Mazin(Founder)

Co-investorsPFPfizer Venture InvestmentsVEVenrock

Women-led biotech company engineering high-performance protein-based textile fibers for fashion with sustainable alternatives to synthetic fibers.

BiotechBrooklyn, US

Valentina Gomez(Executive Officer, Director)inTSTheanne Schiros(Executive Officer)CLChui-lian Lee(Founder)in

BoardCCCorinna Chen(Director)inMKMichael Krel(Director)in

Co-investorsMAMaterial Impact